Favorable therapeutic index of a p210BCR-ABL-specific...

Favorable therapeutic index of a p210BCR-ABL-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors

Bernd Kasper, Stefan Fruehauf, Bernd Schiedlmeier, Elisabeth Buchdunger, Anthony D. Ho, W. Jens Zeller
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
44
Language:
english
Pages:
6
DOI:
10.1007/s002800051001
Date:
September, 1999
File:
PDF, 170 KB
english, 1999
Conversion to is in progress
Conversion to is failed